Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
February 11, 2017
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R)
Vivek Kumar, Amy E Moritz, Thomas M Keck, et al.
Science Signaling
|
February 6, 2020
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sanchez-Soto, Ravi Kumar Verma, Blair K A Willette, et al.
Frontiers in Synaptic Neuroscience
|
March 9, 2018
Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D<sub>2</sub> Dopamine Receptor
Lani S Chun, Rakesh H Vekariya, R Benjamin Free, et al.
RSC Advances
|
July 13, 2026
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
Feijun Wang, John N Hanson, Snezana T Dimova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 14, 2015
Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists
Cheryse A Furman, Rebecca A Roof, Amy E Moritz, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D<sub>3</sub> Dopamine Receptor
Amy E Moritz, Feijun Wang, Nora S Madaras, et al.
Journal of Medicinal Chemistry
|
April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor Agonist
Amy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Biomolecules
|
October 28, 2023
G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D<sub>2</sub> Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation
Marta Sánchez-Soto, Noelia M Boldizsar, Kayla A Schardien, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors
Juan Enriquez-Traba, Hector E Yarur-Castillo, Rodolfo J Flores, et al.
Molecular Pharmacology
|
August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding Sites
Kathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
February 11, 2017
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R)
Vivek Kumar, Amy E Moritz, Thomas M Keck, et al.
Science Signaling
|
February 6, 2020
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sanchez-Soto, Ravi Kumar Verma, Blair K A Willette, et al.
Frontiers in Synaptic Neuroscience
|
March 9, 2018
Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D<sub>2</sub> Dopamine Receptor
Lani S Chun, Rakesh H Vekariya, R Benjamin Free, et al.
RSC Advances
|
July 13, 2026
Synthesis and systematic evaluation of four stereoisomers of BMS compound A enabled by a diastereoselective cyclopropanation on a chiral ketal intermediate
Feijun Wang, John N Hanson, Snezana T Dimova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 14, 2015
Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists
Cheryse A Furman, Rebecca A Roof, Amy E Moritz, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D<sub>3</sub> Dopamine Receptor
Amy E Moritz, Feijun Wang, Nora S Madaras, et al.
Journal of Medicinal Chemistry
|
April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor Agonist
Amy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Biomolecules
|
October 28, 2023
G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D<sub>2</sub> Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation
Marta Sánchez-Soto, Noelia M Boldizsar, Kayla A Schardien, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors
Juan Enriquez-Traba, Hector E Yarur-Castillo, Rodolfo J Flores, et al.
Molecular Pharmacology
|
August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding Sites
Kathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Page
of 3